Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Clinical trial NCT00802802 · COMPLETED
Trial details
- NCT number
- NCT00802802
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-10
- Primary completion
- 2016-03-18
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.